I-PGI

Serial Number 98301831
606

Registration Progress

Application Filed
Dec 6, 2023
Under Examination
Oct 8, 2024
Approved for Publication
Aug 13, 2024
Published for Opposition
Aug 13, 2024
Registered

Attorney Assistance

Abandonment Notice E-Mailed - No Use Statement Filed
Due: Jul 12, 2025 3 days
Revival assistance for abandoned trademark

Trademark Image

I-PGI

Basic Information

Serial Number
98301831
Deadline
July 12, 2025
Description
Trademark Application Revival Due
Filing Date
December 6, 2023
Published for Opposition
August 13, 2024
Abandonment Date
May 12, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 12, 2025
Classes
001 005 042 044

Rights Holder

Tome Biosciences, Inc.

03
Address
100 Talcott Avenue
Watertown, MA 02472

Ownership History

Tome Biosciences, Inc.

Original Applicant
03
Watertown, MA

Tome Biosciences, Inc.

Owner at Publication
03
Watertown, MA

Legal Representation

Attorney
Jennifer Kwon

USPTO Deadlines

Next Deadline
3 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
July 12, 2025

Application History

10 events
Date Code Type Description
May 12, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 12, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Oct 8, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 13, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 13, 2024 PUBO A PUBLISHED FOR OPPOSITION
Jul 24, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 8, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2024 DOCK D ASSIGNED TO EXAMINER
Mar 3, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 001
Biological preparations for scientific use for use in gene therapy, gene editing, gene insertion, and cell therapy
Class 005
Pharmaceutical preparations and biological preparations for medical treatment for use in gene therapy, gene editing, gene insertion, and cell therapy for the treatment of genetic disorders; Pharmaceutical and biological preparations for the treatment of genetic disorders; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, modification, regulation, and repair for use in human therapeutics
Class 042
Medical and scientific research; Medical research and development in the fields of genomic medicine, genome engineering, and cell engineering; Scientific research and development in the field of genomic medicine, genome engineering, and cell engineering; Research and development of pharmaceutical preparations for gene therapy, gene editing, gene insertion, and cell therapy; Providing medical and scientific research information in the fields of genomic medicine, genome engineering, and cell engineering
Class 044
Providing medical and healthcare information in the field of gene sequencing, gene editing, and gene insertion technologies; Providing medical and healthcare information regarding gene therapies and cell therapies

Classification

International Classes
001 005 042 044